Emerging antimicrobial resistance pattern of Helicobacter pylori in central Gujarat

Indian Journal of Medical Microbiology

Volumn 32, Issue 4, 2014, Pages 408-413

  Pandya, H B ^a   Agravat, Harihar Har ^b   Patel, J S ^c   Sodagar, N R K ^a  

^a P M Patel Paramedical Institute   (India)

^b Chiman Bhai Odhav Bhai Shah Medical College   (India)

^c CHAROTAR UNIVERSITY OF SCIENCE AND TECHNOLOGY   (India)

Author keywords

Amoxicillin; clarithromycin; H.pylori; metronidazole; Resistance

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; CLARITHROMYCIN; ERYTHROMYCIN; FURAZOLIDONE; LEVOFLOXACIN; METRONIDAZOLE; TETRACYCLINE; ANTIINFECTIVE AGENT; CULTURE MEDIUM;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CHILD; DUODENITIS; DUODENUM BIOPSY; DUODENUM ULCER; FEMALE; GASTRITIS; GROUPS BY AGE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; REFLUX ESOPHAGITIS; SENSITIVITY ANALYSIS; SEX DIFFERENCE; ULCER; BIOPSY; CHEMISTRY; CULTURE MEDIUM; DRUG EFFECTS; HELICOBACTER INFECTIONS; INDIA; INTESTINE MUCOSA; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; PREVALENCE; STOMACH MUCOSA; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BIOPSY; CHILD; CULTURE MEDIA; DRUG RESISTANCE, BACTERIAL; FEMALE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INDIA; INTESTINAL MUCOSA; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PREVALENCE; YOUNG ADULT;

EID: 84908007906     PISSN: 02550857     EISSN: 19983646     Source Type: Journal    
DOI: 10.4103/0255-0857.142256     Document Type: Article

References (23)

1. Rauws EA, Langenberg W, Houthoff HJ, Zanen HC, Tytgat GN. Campylobacter pylori associated with chronic active antral gastritis. A prospective study of it prevalence and the effect of antibacterial and antiulcer treatment. Gastroenterology 1988;94:33-40.
2. Dergisi GT. Diagnostic methods of Helicobacter pylori infection. Emel Öztürk 2008;50:60-4.
3. Lind T, Veldhuyzen van Zanten S, Unge P, Spiller R, Bayerdörffer E, O'Morain C, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: The MACH I Study. Helicobacter 1996;1:138-44.
4. Huang JQ, Hunt RH. Treatment after failure: The problem of "Non-responders". Gut 1999;45:140-4.
5. Mendonça S, Ecclissato C, Sartori MS, Godoy AP, Guerzoni RA, Degger M, et al. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in Brazil. Helicobacter 2000;5:79-83.
6. Destura RV, Labio ED, Barrett LJ, Alcantara CS, Gloria VI, Daez ML, et al. Laboratory diagnosis and susceptibility profile of Helicobacter pylori infection in the Philippines. Ann Clin Microbiol Antimicrob 2004;3:25.
7. Clinical Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty First Informational Supplement. CLSI document M100-S21. Wayne: CLSI;2011.
8. Bindayna KM. Antibiotic susceptibilities of Helicobacter pylori. Saudi Med J 2001;22:53-7.
9. Kulsuntiwong P, Chomvarin C, Chaicumpar K, Namwat W, Kaewkes W, Mairiang P, et al. Antimicrobial susceptibility of helicobacter pylori isolated from gastric biopsies in dyspeptic patients. Southeast Asian J Trop Med Public Health 2008;39:1102-9.
10. Mirza IA, Mirza SH, Ali AM. Antimicrobial susceptibility pattern of H. pylori in isolates from Northern Pakistan. Int J Pathol 2007;5:18-20.
11. Datta S, Chattopadhyay S, Patra R, De R, Ramamurthy T, Hembram J, et al. Most Helicobacter pylori strains of Kolkata in India are resistant to MTZ but susceptible to other drugs commonly used for eradication and ulcer therapy. Aliment Pharmacol Ther 2005;22:51-7.
12. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: A global evidence based consensus. Am J Gastroenterol 2006;101:1900-20.
13. Saha DR. Correlation of histology with genotypes of Helicobacter pylori isolated from cases of peptic ulcer, non-ulcer dyspepsia, gastric carcinoma and lymphoma. National Institute of Cholera And Enteric Diseases (NICED) Annual Report 2004-2005.
14. Kobayashi T, Kikuchi S, Lin Y, Yagyu K, Obata Y, Ogihara A, et al. Trends in the incidence of gastric cancer in Japan and their associations with Helicobacter pylori infection and gastric mucosal atrophy. Gastric Cancer 2004;7:233-9.
15. Singh V, Mishra S, Maurya P, Rao G, Jain AK, Dixit VK, et al. Drug resistance pattern and clonality in H. pylori strains. J Infect Dev Ctries 2009;3:130-6.
16. Thyagarajan SP, Ray P, Das BK, Ayyagari A, Khan AA, Dharmalingam S, et al. Geographical difference in antimicrobial resistance pattern of Helicobacter pylori clinical isolates from Indian patients: Multicentric study. J Gastroenterol Hepatol 2003;18:1373-8.
17. Matsumura M, Hikiba Y, Ogura K, Togo G, Tsukuda I, Ushikawa K, et al. Rapid detection of mutations in the 23S rRNA gene of Helicobacter pylori that confers resistance to clarithromycin treatment to the bacterium. J Clin Microbiol 2001;39:691-5.
18. Paul R, Postius S, Melchers K, Schäfer KP. Mutations of the Helicobacter pylori genes rdxA and pbp1 cause resistance against metronidazole and amoxicillin. Antimicrob Agents Chemother 2001;45:962-5.
19. Midolo PD, Lambert JR, Russell EG, Lin SK. A practical single sample dry latex agglutination test for Helicobacter pylori antibody detection. J Clin Pathol 1995;48:969-71.
20. Boyanova L, Koumanova R, Gergova G, Popova M, Mitov I, Kovacheva Y, et al. Prevalence of resistant Helicobacter pylori isolates in Bulgarian children. J Med Microbiol 2002;51:786-90.
21. Loivukene K, Maaroos HI, Kolk H, Kull I, Labotkin K, Mikelsaar M. Prevalence of antibiotic resistance of Helicobacter pylori isolates in Estonia during 1995-2000 in comparison to the consumption of antibiotics used in treatment regimens. Clin Microbiol Infect 2002;8:598-603.
22. Godoy AP, Ribeiro ML, Benvengo YH, Vitiello L, Miranda Mde C, Mendonca S, et al. Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates. BMC Gastroenterol 2003;3:20.
23. Kawakami E, Machado RS, Ogata SK, Langner M, Fukushima E, Carelli AP, et al. Furazolidone-based triple therapy for H. pylori gastritis in children. World J Gastroenterol 2006;12:5544-9.